- ScreenPro (SCRN) administered 29,519 Covid-19 tests in April, an increase of 15 per cent compared to March’s testing numbers
- The company’s core business in Covid testing remains strong with an increase in sales in April
- ScreenPro is a screening and medical technology company that provides turnkey screening solutions
- ScreenPro Security is a medical technology company that offers proprietary testing methods and medical alerting software
- ScreenPro Security Inc. (SCRN) opened trading at C$0.055 per share
ScreenPro (SCRN) administered 29,519 Covid-19 tests in April, an increase of 15 per cent compared to March’s Covid testing numbers of 25,517.
With the recent news of Toronto’s mayor terminating the Covid-19 emergency declaration that was put in place at the beginning of the pandemic in March 2020 and the surge of cases with the new omicron subvariants worldwide, the company is confident that Covid testing numbers and market share will continue to increase significantly as testing demand is growing each month within the community.
Lena Kozovski, ScreenPro CEO commented on the update.
“We are pleased that our core business in Covid testing remains strong with an increase of sales in April. As infections continue to trend upwards, we foresee our testing sales to increase further.”
ScreenPro is a screening and medical technology company that provides turnkey screening solutions with its proprietary medical alerting software.
ScreenPro’s access to multiple manufacturers of high-quality test kits and its strategic partnership with labs in British Columbia, Ontario and Quebec allows ScreenPro to provide COVID testing solutions across Canada.
ScreenPro has its own medical doctor and nursing professionals with on-the-ground support staff and transportation, with access to high-quality PPEs to ensure that clients are protected in all aspects of their testing needs.
ScreenPro Security Inc. (SCRN) opened trading at C$0.055 per share.
